Pathological analysis of abnormal activation for peptidylarginine deiminase in brain
Pathological analysis of abnormal activation for peptidylarginine deiminase in brain
批准号:
17590326
负责人:
KUBO Sachiho
金额:
$2.3万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Citrullinated proteins are the products of a post-translational process in which arginine residues undergo modification into citrulline residues when catalyzed by peptidylarginine deiminases (PADs) in a calcium ion-dependent manner. In our previous report, PAD2 expressed mainly in the rat cerebrum became activated early in the neurodegenerative process. To elucidate the involvement of protein citrullination in human neuronal degeneration, we examined whether citrullinated proteins are produced during Alzheimer's disease (AD). By Western blot analysis using anti-modified citrulline antibody, citrullinated proteins of varied molecular weights were detected in hippocampal tissues from patients with AD but not normal humans. Two of the citrullinated proteins were identified as vimentin and glial fibrillary acidic protein (GFAP) by using two-dimensional gel electrophoresis and MALDI-TOF mass spectrometry. Interestingly, PAD2 was detected in hippocampal extracts from AD and normal brains, bu … More t the amount of PAD2 in the AD tissue was markedly greater. Histochemical analysis revealed citrullinated proteins throughout the hippocampus, especially in the dentate gyrus and stratum radiatum of CA1 and CA2 areas. However, no citrullinated proteins were detected in the normal hippocampus. PAD2 immunoreactivity was also ubiquitous throughout both the AD and normal hippocampal areas. PAD2-enrichment coincided well with citrullinated protein-positivity. Double immunofluorescence staining revealed that citrullinated protein- and PAD2-positive cells also coincided with GFAP-positive cells, but not all GFAP-positive cells were positive for PAD2. Like GFAP, which is an astrocyte-specific marker protein, PAD2 is distributed mainly in astrocytes. These collective results, the abnormal accumulation of citrullinated proteins and abnormal activation of PAD2 in hippocampi of patients with AD, strongly suggest that PAD has an important role in the onset and progression of AD and that citrullinated proteins may became a useful marker for human neurodegenerative diseases. Less
期刊论文(13)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.14670/hh-21.1151
发表时间:
2006-11
期刊:
Histology and histopathology
影响因子:
2
作者:
[W. Yumura;T. Imasawa;S. Suganuma;A. Ishigami;S. Handa;S. Kubo;K. Joh;N. Maruyama]
通讯作者:
W. Yumura;T. Imasawa;S. Suganuma;A. Ishigami;S. Handa;S. Kubo;K. Joh;N. Maruyama
DOI:
10.1073/pnas.0511225103
发表时间:
2006-04-11
期刊:
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
影响因子:
11.1
作者:
[Kondo, Y, Inai, Y, Ishigami, A]
通讯作者:
Ishigami, A
抗MuSK抗体陽性重症筋無力症の病因と病態
抗MuSK抗体阳性重症肌无力的病因和病理
DOI:
--
发表时间:
2006
期刊:
基礎老化研究 30
影响因子:
--
作者:
[重本和宏, 久保幸穂, 丸山直記]
通讯作者:
丸山直記
蛋白質のシトルリン化と病態
蛋白质瓜氨酸化和病理学
DOI:
--
发表时间:
2005
期刊:
最新医学 60
影响因子:
--
作者:
[丸山直記, 石神昭人]
通讯作者:
石神昭人
アルツハイマー病でのシトルリン化蛋白質の異常な蓄積
阿尔茨海默病中瓜氨酸蛋白的异常积累
DOI:
--
发表时间:
2005
期刊:
日本未病システム学会雑誌 11
影响因子:
--
作者:
[Takeshita M, et al., 石神昭人 他]
通讯作者:
石神昭人 他
共 11 条
Analysis of pathogenic mechanisms of myasthenia gravis.
-
批准号:19590374
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2007
-
负责人:KUBO Sachiho
-
依托单位:
国内基金
海外基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
-
批准号:81000622
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:梁胜
-
依托单位:
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
-
批准号:31060293
-
项目类别:地区科学基金项目
-
资助金额:26.0万元
-
批准年份:2010
-
负责人:郭亚芬
-
依托单位:
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
-
批准号:30960334
-
项目类别:地区科学基金项目
-
资助金额:22.0万元
-
批准年份:2009
-
负责人:董贵成
-
依托单位: